References
Korkmaz C (2005) Is there a hypothalamic–pituitary–adrenal axis dysfunction in patients with familial Mediterranean fever? Clin Rheumatol 20:1–2. DOI 10.1007/s10067-005-0083-3
Tansu S, Omer O, Fahrettin K, Sebnem G, Mevlut B, Mustafa K, Munis D (2005) Adrenal axis functions in patients with familial Mediterranean fever. Clin Rheumatol 3:1–4. DOI 10.1007/s10067-005-0152-7
Schaner PE, Gumucio DL (2005) Familial Mediterranean fever in the post-genomic era: how an ancient disease is providing new insights into inflammatory pathways. Curr Drug Targets Inflamm Allergy 4(1):67–76
Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S, Pras M, Livneh A (2001) Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 15 102(3):272–276
Melikoglu M, Ozdogan H, Kormaz C, Kasapcopur O, Arisoy N, Akkus F (2000) A survey of phenotype II in familial Mediterranean fever. Ann Rheum Dis 59:910–913
Mamou H (1970) Etat actuel de la maladie periodique. Presse Med 78:727–728
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Konstantopoulos, K. Endocrine function and dysfunction in familial Mediterranean fever. Clin Rheumatol 25, 885 (2006). https://doi.org/10.1007/s10067-006-0209-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0209-2